Related Experiment Videos
Systemic lupus erythematosus in childhood
Marisa Klein-Gitelman1, Andreas Reiff, Earl D Silverman
1Division of Immunology/Rheumatology, Department of Pediatrics, Children's Memorial Hospital, Northwestern University, Chicago, IL, USA.
Rheumatic Diseases Clinics of North America
|October 17, 2002
Summary
Systemic lupus erythematosus (SLE) is an immune disorder affecting about 1 in 2000 people, often young women. Pediatric SLE requires careful treatment considering developmental stages.
Area of Science:
- Immunology
- Pediatrics
- Rheumatology
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by immune dysregulation.
- It affects approximately 1 in 2000 individuals, with a predilection for young women of child-bearing age.
- SLE can manifest at any age, across all ethnic backgrounds and sexes, with 20% of cases diagnosed in the first two decades of life.
Purpose of the Study:
- To highlight the unique considerations for treating pediatric patients with systemic lupus erythematosus.
- To emphasize the importance of addressing the physical, intellectual, and emotional development of children undergoing lupus treatment.
Main Methods:
- This abstract does not detail specific methods but focuses on the clinical presentation and treatment considerations of SLE.
- It emphasizes the need for a developmental-stage-aware approach in pediatric SLE management.
Main Results:
- Systemic lupus erythematosus affects individuals across all demographics, including a significant proportion of children and adolescents.
- The diagnosis of SLE in early life necessitates a treatment strategy that accounts for ongoing development.
Conclusions:
- Pediatric SLE presents distinct challenges requiring specialized care.
- Treatment protocols for children with SLE must integrate developmental considerations to optimize outcomes.